Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

References

• Genga KR, Russell JA. Update of sepsis in the intensive care unit. J Innate Immun. 2017;9(5):441–455. doi:10.1159/000477419
   PubMed Web of Science ®Google Scholar
• Fleischmann-Struzek C, Mellhammar L, Rose N, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1552–1562. doi:10.1007/s00134-020-06151-x
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31(12):2742–2751. doi:10.1097/01.CCM.0000098031.24329.10
   PubMed Web of Science ®Google Scholar
• Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–1596. doi:10.1097/01.CCM.0000217961.75225.E9
   PubMed Web of Science ®Google Scholar
• Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063–e1143. doi:10.1097/CCM.0000000000005337
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228. doi:10.1007/s00134-012-2769-8
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377. doi:10.1007/s00134-017-4683-6
   PubMed Web of Science ®Google Scholar
• Becker B, Cooper MA. Aminoglycoside antibiotics in the 21st century. ACS Chem Biol. 2013;8(1):105–115. doi:10.1021/cb3005116
   PubMed Web of Science ®Google Scholar
• Hansen M, Christrup LL, Jarlov JO, Kampmann JP, Bonde J. Gentamicin dosing in critically ill patients. Acta Anaesthesiol Scand. 2001;45(6):734–740. doi:10.1034/j.1399-6576.2001.045006734.x
   PubMed Web of Science ®Google Scholar
• Fuchs A, Guidi M, Giannoni E, et al. Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates. Br J Clin Pharmacol. 2014;78(5):1090–1101. doi:10.1111/bcp.12444
   PubMed Web of Science ®Google Scholar
• Petejova N, Zahalkova J, Duricova J, et al. Gentamicin pharmacokinetics during continuous venovenous hemofiltration in critically ill septic patients. J Chemother. 2012;24(2):107–112. doi:10.1179/1120009X12Z.0000000006
   PubMed Web of Science ®Google Scholar
• Veinstein A, Venisse N, Badin J, Pinsard M, Robert R, Dupuis A. Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered. Antimicrob Agents Chemother. 2013;57(2):977–982. doi:10.1128/AAC.01762-12
   PubMed Web of Science ®Google Scholar
• Roberts JA, Field J, Visser A, et al. Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury. Antimicrob Agents Chemother. 2010;54(9):3635–3640. doi:10.1128/AAC.00222-10
   PubMed Web of Science ®Google Scholar
• Ambrose PG, Jones RN. Aminoglycoside in vitro Susceptibility Test Interpretive Criteria Evaluations. USCAST 0002; 2019.
   Google Scholar
• Chuk AC, Saeed F, Kousar N, et al. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration. Clin Nephrol. 2015;84(10):214–221. doi:10.5414/CN108559
   PubMedGoogle Scholar
• Bos JC, Prins JM, Misticio MC, et al. Population pharmacokinetics with Monte Carlo simulations of gentamicin in a population of severely ill adult patients from Sub-Saharan Africa. Antimicrob Agents Chemother. 2019;63(4). doi:10.1128/AAC.02328-18
   PubMed Web of Science ®Google Scholar
• Hodiamont CJ, Juffermans NP, Bouman CS, de Jong MD, Mathot RA, van Hest RM. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis. Int J Antimicrob Agents. 2017;49(2):204–211. doi:10.1016/j.ijantimicag.2016.10.022
   PubMed Web of Science ®Google Scholar
• Ernest D, Cutler DJ. Gentamicin clearance during continuous arteriovenous hemodiafiltration. Crit Care Med. 1992;20(5):586–589. doi:10.1097/00003246-199205000-00007
   PubMed Web of Science ®Google Scholar
• Tang GJ, Tang JJ, Lin BS, Kong CW, Lee TY. Factors affecting gentamicin pharmacokinetics in septic patients. Acta Anaesthesiol Scand. 1999;43(7):726–730. doi:10.1034/j.1399-6576.1999.430707.x
   PubMed Web of Science ®Google Scholar
• Bellomo R, Kellum JA, Ronco C, et al. Acute kidney injury in sepsis. Intensive Care Med. 2017;43(6):816–828. doi:10.1007/s00134-017-4755-7
   PubMed Web of Science ®Google Scholar
• Tandukar S, Palevsky PM. Continuous renal replacement therapy who, when, why, and how. Chest. 2019;155(3):626–638. doi:10.1016/j.chest.2018.09.004
   PubMed Web of Science ®Google Scholar
• Radigan EA, Gilchrist NA, Miller MA. Management of aminoglycosides in the intensive care unit. J Intensive Care Med. 2010;25(6):327–342. doi:10.1177/0885066610377968
   PubMedGoogle Scholar
• Xie F, Li S, Cheng Z. Population pharmacokinetics and dosing considerations of daptomycin in critically ill patients undergoing continuous renal replacement therapy. J Antimicrob Chemother. 2020;75(6):1559–1566. doi:10.1093/jac/dkaa028
   PubMed Web of Science ®Google Scholar
• D’Arcy DM, Corrigan OI, Deasy E, Gowing CM, Donnelly MB. Gentamicin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration (CVVHDF). Eur J Clin Pharmacol. 2015;71(3):377–378. doi:10.1007/s00228-014-1765-z
   PubMed Web of Science ®Google Scholar
• Baud FJ, Houze P, Carli P, Lamhaut L. Alteration of the pharmacokinetics of aminoglycosides by adsorption in a filter during continuous renal replacement therapy. An in vitro assessment. Therapie. 2020;76(5):415–424.
   PubMed Web of Science ®Google Scholar
• Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011;13(2):143–151. doi:10.1208/s12248-011-9255-z
   PubMed Web of Science ®Google Scholar
• Johnson AEW, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3(1):160035. doi:10.1038/sdata.2016.35
   PubMed Web of Science ®Google Scholar
• Boisson M, Mimoz O, Hadzic M, et al. Pharmacokinetics of intravenous and nebulized gentamicin in critically ill patients. J Antimicrob Chemother. 2018;73(10):2830–2837. doi:10.1093/jac/dky239
   PubMed Web of Science ®Google Scholar
• Rea RS, Capitano B, Bies R, Bigos KL, Smith R, Lee H. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit. 2008;30(6):674–681. doi:10.1097/FTD.0b013e31818b6b2f
   PubMed Web of Science ®Google Scholar
• Bukkems LH, Roger C, Hodiamont CJ, et al. Predictive performance of a gentamicin population pharmacokinetic model in two western populations of critically ill patients. Int J Antimicrob Agents. 2018;52(2):218–225. doi:10.1016/j.ijantimicag.2018.04.016
   PubMed Web of Science ®Google Scholar
• D’Arcy DM, Casey E, Gowing CM, Donnelly MB, Corrigan OI. An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration. BMC Pharmacol Toxicol. 2012;13:14. doi:10.1186/2050-6511-13-14
   PubMed Web of Science ®Google Scholar
• Blot SI, Pea F, Lipman J. The effect of pathophysiology on pharmacokinetics in the critically ill patient–concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev. 2014;77:3–11. doi:10.1016/j.addr.2014.07.006
   PubMed Web of Science ®Google Scholar
• Goncalves-Pereira J, Martins A, Povoa P. Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose. Clin Microbiol Infect. 2010;16(8):1258–1263. doi:10.1111/j.1469-0691.2009.03074.x
   PubMed Web of Science ®Google Scholar
• Hodiamont CJ, Janssen JM, de Jong MD, Mathot RA, Juffermans NP, van Hest RM. Therapeutic drug monitoring of gentamicin peak concentrations in critically ill patients. Ther Drug Monit. 2017;39(5):522–530. doi:10.1097/FTD.0000000000000432
   PubMed Web of Science ®Google Scholar